Drilling into controversies in field of asymptomatic severe carotid stenosis management

374
Ali AbuRahma

Some of the enduring controversies in the management of asymptomatic severe carotid stenosis will underpin an educational session set to take place today.

The session tackles debate around the deployment of carotid revascularization strategies in both standard- and high-risk patient populations. It takes place on the Morial Convention Center’s Second Floor (Room 208–210) from 3:30–5 p.m. and will be hosted by carotid disease luminaries Ali AbuRahma, MD, former SVS president and chief of vascular surgery at West Virginia University/Charleston Area Medical Center, alongside Raghu Motaganahalli, MD, chief of vascular surgery at Indiana University School of Medicine in Indianapolis.

AbuRahma will open the session with an introduction to controversies in the field.

Bruce Perler, MD, another former SVS president and vascular chief emeritus at Johns Hopkins University School of Medicine in Baltimore, Maryland, will argue that carotid endarterectomy (CEA) should be the first-line therapy in standard-risk patients, before Marc Schermerhorn, MD, chief of vascular surgery at Beth Israel Deaconess Medical Center in Boston, makes the case for transcarotid artery revascularization (TCAR). Peter Schneider, MD, professor of surgery at the University of California, San Francisco will argue for transfemoral carotid artery stenting (TFCAS).

Brajesh Lal, MD, professor of vascular surgery at the University of Maryland in Baltimore, will update attendees on the status of the much-anticipated CREST-2 trial.

Similarly, three vascular surgeons will make the respective cases for the same three carotid revascularization strategies as the first-line therapy in high-risk asymptomatic patients: Wei Zhou, MD, chief of vascular surgery at the University of Arizona in Tucson, for CEA; Caitlin Hicks, MD, associate professor of surgery at the Johns Hopkins, for TCAR; and Sean Lyden, MD, chairman of vascular surgery at the Cleveland Clinic in Cleveland, Ohio, for TFCAS. The session will finish with a specific look at female patients by Yana Etkin, MD, associate professor of surgery at Zucker School of Medicine at Hofstra/Northwell in New York.

LEAVE A REPLY

Please enter your comment!
Please enter your name here